Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for April 14th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 14th:

Louisiana-Pacific Corporation (LPX - Free Report) : This company that manufactures building materials and engineered wood products has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 58.7% over the last 60 days.

 

Louisiana-Pacific has a price-to-earnings ratio (P/E) of 8.66, compared with 16.90 for the industry. The company possesses a Value Score of B.

 

Textainer Group Holdings Limited : This company that purchases, owns, manages, leases, and disposes a fleet of intermodal containers has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 74.7% over the last 60 days.

 

Textainer Group has a price-to-earnings ratio (P/E) of 7.48, compared with 34.60 for the industry. The company possesses a Value Score of A.

 

Mid Penn Bancorp, Inc. (MPB - Free Report) : This bank holding company for Mid Penn Bank has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 13.9% over the last 60 days.

 

Mid Penn Bancorp has a price-to-earnings ratio (P/E) of 7.79, compared with 13.50 for the industry. The company possesses a Value Score of B.

 

Oasis Midstream Partners LP : This company that owns, develops, operates and acquires a diversified portfolio of midstream assets has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 12.2% over the last 60 days.

 

Oasis Midstream Partners has a price-to-earnings ratio (P/E) of 7.29, compared with 9.40 for the industry. The company possesses a Value Score of B.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Louisiana-Pacific Corporation (LPX) - free report >>

Mid Penn Bancorp (MPB) - free report >>

Published in